Industry
Biotechnology
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Henry Khederian
September 26, 2023 | 2:57 pm
Portfolio Pulse from Benzinga Newsdesk
September 26, 2023 | 2:27 pm
Portfolio Pulse from Bill Haddad
September 26, 2023 | 12:01 pm
Portfolio Pulse from Benzinga Newsdesk
July 10, 2023 | 1:08 pm
Portfolio Pulse from Happy Mohamed
July 07, 2023 | 12:03 pm
Portfolio Pulse from Lisa Levin
July 05, 2023 | 5:29 pm
Portfolio Pulse from Benzinga Newsdesk
July 05, 2023 | 1:03 pm
Portfolio Pulse from Benzinga Newsdesk
June 23, 2023 | 12:33 pm
Portfolio Pulse from Benzinga Insights
June 23, 2023 | 12:20 pm
Portfolio Pulse from Benzinga Newsdesk
June 23, 2023 | 11:47 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.